The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by T. Rowe Price Investment Management Inc.

T. Rowe Price Investment Management Inc. boosted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.1% in the fourth quarter, HoldingsChannel reports. The firm owned 7,678,965 shares of the medical device company’s stock after buying an additional 155,233 shares during the period. T. Rowe Price Investment Management Inc.’s holdings in Cooper Companies were worth $705,928,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in the business. Fulton Bank N.A. increased its holdings in Cooper Companies by 3.0% in the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after buying an additional 109 shares in the last quarter. Covestor Ltd increased its holdings in Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company’s stock worth $42,000 after acquiring an additional 120 shares in the last quarter. Torray Investment Partners LLC raised its position in Cooper Companies by 0.8% during the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock worth $1,488,000 after acquiring an additional 132 shares during the period. Mather Group LLC. lifted its holdings in Cooper Companies by 7.4% during the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock valued at $177,000 after purchasing an additional 133 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB lifted its holdings in Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after purchasing an additional 136 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $79.79 on Wednesday. The business’s 50 day moving average price is $82.52 and its 200 day moving average price is $93.20. The company has a market cap of $15.96 billion, a price-to-earnings ratio of 40.92, a PEG ratio of 2.25 and a beta of 1.01. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a one year low of $69.81 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. The business had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on COO shares. JPMorgan Chase & Co. reduced their price target on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a research report on Friday, March 7th. Piper Sandler reissued an “overweight” rating and set a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. BNP Paribas raised Cooper Companies to a “hold” rating in a research note on Thursday, March 13th. Stifel Nicolaus dropped their price target on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a research report on Friday, March 7th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.